Canada launches antitrust investigation into Express Scripts
Canada’s Competition Bureau has opened an antitrust investigation into Cigna’s Express Scripts unit, seeking to probe its business practices in...
Evernorth expands NeuroStar coverage to adolescents
Cigna’s Evernorth unit is expanding coverage for Neuronetics’ therapy for depression to adolescents. Neuronetics announced that Evernorth will offer coverage...
A look at the progress toward value-based care in mental health
Behavioral health has lagged behind in the shift to value-based care, and a new paper from experts at Cigna outlines...
Cigna unveils initiatives aimed at improving customer experience
Cigna is officially kicking off a multiyear effort designed to “meaningfully” change the experience of its members. Executives alluded to...
Cigna-Humana merger talks are back on: report
Cigna has brought merger talks with Humana back from the dead, according to a new report in Bloomberg. People familiar...
MA Star ratings 2025—Who are the winners and losers?
Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the...
Accredo to make Stelara biosimilar available at $0 out-of-pocket
Evernorth’s Accredo specialty pharmacy will offer biosimilars for the popular immunotherapy Stelara at $0 for eligible patients, the company announced...
Chutes & Ladders—NAHC-NHPCO Alliance’s inaugural CEO and more
Welcome to this week’s Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the...
Medicaid, MA headwinds pressure payers in Q2
Medicare Advantage (MA) and Medicaid woes continued to plague some major payers in the second quarter, with UnitedHealth Group regaining...
